02256

5.6807.94%
HY

Hoi Yam Chui

Independent Non-Executive Director

Ms. Hoi Yam Chui is Independent Non-Executive Director of Sinohealth Technology Holdings Limited (formerly known as Sinohealth Holdings Limited) from December 3, 2025. Ms. Chui is Independent Non-Executive Director of TransThera Sciences (Nanjing), Inc. (formerly known as Nanjing TransThera Biosciences Co. Ltd.) from October 17, 2022. She is primarily responsible for supervising and providing independent opinion to our Board. Ms. Chui is Independent Non-Executive Director of Abbisko Medicine Co., Ltd. (formerly known as Abbisko Cayman Limited) from February 28, 2025. She is Independent Non-Executive Director of Everest Medicines Limited from January 19, 2023. Ms. Chui was Non-Executive Director of China Biotech Services Holdings Limited from June 30, 2023 to June 13, 2024. She was Executive Director of China Biotech Services Holdings Limited from December 05, 2022 until June 30, 2023 and since June 30, 2023 serves as its Non-Executive Director. She was the President of Harbin Pharmaceutical Group Co. Ltd. from March 2019 to May 2022 and was a Director of Harbin Pharmaceutical from January 2021 to May 2022. She has previously worked in China Hewlett-Packard Co. Ltd. and Novartis International. She has Master's in Finance from Peking University in July 2001, Bachelor's in Economic Administration from Peking University in 1990.

Positions